Enterovirus D68-specific monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Enterovirus D68-specific monoclonal antibody, covering 2025-10-31 to 2025-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults [Phase 1]